Business Description
Boundless Bio Inc
NAICS : 541713
SIC : 2833
Description
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 55.01 | |||||
| Equity-to-Asset | -0.98 | |||||
| Debt-to-Equity | -0.02 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.51 | |||||
| 9-Day RSI | 26.94 | |||||
| 14-Day RSI | 20.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.27 | |||||
| Quick Ratio | 13.27 | |||||
| Cash Ratio | 12.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -20.04 | |||||
| ROIC % | -230.29 | |||||
| ROC (Joel Greenblatt) % | -428.27 | |||||
| ROCE % | -24.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -4.62 | |||||
| EV-to-EBITDA | -4.7 | |||||
| EV-to-FCF | -2.8 | |||||
| Earnings Yield (Greenblatt) % | -21.65 | |||||
| FCF Yield % | -21.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BOLD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Boundless Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.138 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 20.74 | ||
| 14-Day ATR ($) | 0.865545 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 9.94 - 15.24 | ||
| Shares Outstanding (Mil) | 22.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Boundless Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Boundless Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Boundless Bio Inc Frequently Asked Questions
What is Boundless Bio Inc(BOLD)'s stock price today?
The current price of BOLD is $10.07. The 52 week high of BOLD is $15.24 and 52 week low is $9.94.
When is next earnings date of Boundless Bio Inc(BOLD)?
The next earnings date of Boundless Bio Inc(BOLD) is .
Does Boundless Bio Inc(BOLD) pay dividends? If so, how much?
Boundless Bio Inc(BOLD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers